Ion Channel Drugs Suppress Cancer Phenotype in NG108-15 and U87 Cells: Toward Novel Electroceuticals for Glioblastoma

SIMPLE SUMMARY: Glioblastoma is a rapidly progressing brain cancer that is very difficult to treat. Given that many aspects of cell and tissue behavior are controlled by electric signaling, we sought to test whether drugs that target ion channel proteins might be effective at controlling the spread...

Descripción completa

Detalles Bibliográficos
Autores principales: Mathews, Juanita, Kuchling, Franz, Baez-Nieto, David, Diberardinis, Miranda, Pan, Jen Q., Levin, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946312/
https://www.ncbi.nlm.nih.gov/pubmed/35326650
http://dx.doi.org/10.3390/cancers14061499

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946312/
https://www.ncbi.nlm.nih.gov/pubmed/35326650
http://dx.doi.org/10.3390/cancers14061499

Ejemplares similares